S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BioAtlaMesa LaboratoriesZealand Pharma A/SAmneal PharmaceuticalsCytokinetics
SymbolNASDAQ:BCABNASDAQ:MLABNASDAQ:ZEALNYSE:AMRXNASDAQ:CYTK
Price Information
Current Price$48.39$268.90$30.99$4.95$19.68
52 Week RangeBuyHoldBuyHoldBuy
MarketRank™
Overall Score1.61.51.21.61.7
Analysis Score1.51.03.51.23.5
Community Score5.02.62.52.23.5
Dividend Score0.01.70.00.00.0
Ownership Score1.71.70.00.01.7
Earnings & Valuation Score0.00.60.04.40.0
Analyst Ratings
Consensus RecommendationBuyHoldBuyHoldBuy
Consensus Price Target$48.00$273.50$43.00$5.13$32.00
% Upside from Price Target-0.81% downside1.71% upside38.75% upside3.54% upside62.60% upside
Trade Information
Market Cap$1.55 billion$1.38 billion$1.35 billion$1.48 billion$1.40 billion
BetaN/A0.391.191.271.45
Average Volume245,29523,56315,5721,768,419887,019
Sales & Book Value
Annual RevenueN/A$117.69 million$6.20 million$1.63 billion$26.87 million
Price / SalesN/A11.73216.930.9152.08
CashflowN/A$9.07 per shareN/A$1.15 per shareN/A
Price / CashN/A29.65N/A4.29N/A
Book ValueN/A$50.34 per share$5.85 per share$1.16 per share($0.19) per share
Price / BookN/A5.345.304.27-103.58
Profitability
Net IncomeN/A$1.35 million$-85,670,000.00$-361,920,000.00$-121,690,000.00
EPSN/A$4.21($2.54)$0.27($2.11)
Trailing P/E Ratio0.00N/AN/A12.07N/A
Forward P/E RatioN/A43.23N/A7.50N/A
P/E GrowthN/AN/AN/A0.29N/A
Net MarginsN/A-2.04%-214.31%3.30%-209.88%
Return on Equity (ROE)N/A6.39%-38.34%42.02%-3,065.14%
Return on Assets (ROA)N/A3.91%-30.40%3.82%-36.39%
Dividend
Annual PayoutN/A$0.64N/AN/AN/A
Dividend YieldN/A0.24%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A15.20%N/AN/AN/A
Years of Consecutive Dividend GrowthN/A1 YearsN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.36%N/A8.20%0.90%
Current RatioN/A14.34%6.76%2.31%15.18%
Quick RatioN/A13.74%6.51%1.60%15.17%
Ownership Information
Institutional Ownership PercentageN/A93.54%4.32%33.49%97.13%
Insider Ownership PercentageN/A6.10%N/A26.32%6.40%
Miscellaneous
EmployeesN/A4603295,500156
Shares Outstanding32.09 million5.13 million43.40 million299.82 million71.11 million
Next Earnings DateN/A6/7/2021 (Estimated)3/11/2021 (Confirmed)5/10/2021 (Estimated)5/5/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.